Related references
Note: Only part of the references are listed.Investigation of flap flexibility of β-secretase using molecular dynamic simulations
Hezekiel M. Kumalo et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2016)
CryptoSite: Expanding the Druggable Proteome by Characterization and Prediction of Cryptic Binding Sites
Peter Cimermancic et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Understanding Cryptic Pocket Formation in Protein Targets by Enhanced Sampling Simulations
Vladimiras Oleinikovas et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Gating by Tryptophan 73 Exposes a Cryptic Pocket at the Protein-Binding Interface of the Oncogenic eIF4E Protein
Dilraj Lama et al.
BIOCHEMISTRY (2015)
Prospects of -Secretase Inhibitors for the Treatment of Alzheimer's Disease
Arun K. Ghosh et al.
CHEMMEDCHEM (2015)
Discovery of multiple hidden allosteric sites by combining Markov state models and experiments
Gregory R. Bowman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Epock: rapid analysis of protein pocket dynamics
Benoist Laurent et al.
BIOINFORMATICS (2015)
Computational Methods in the Discovery and Design of BACE-1 Inhibitors
P. Kacker et al.
CURRENT MEDICINAL CHEMISTRY (2015)
BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer's disease
Arun K. Ghosh et al.
CHEMICAL SOCIETY REVIEWS (2014)
Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents
Elisabet Viayna et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids
Sergio Ruiz-Carmona et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Allosteric inhibition of BACE1 by an exosite-binding antibody
Weiru Wang et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2013)
Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease
Jing Yuan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Using Ligand-Mapping Simulations to Design a Ligand Selectively Targeting a Cryptic Surface Pocket of Polo-Like Kinase 1
Yaw Sing Tan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases
Caries Galdeano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
New Tacrine-4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties
Maria Isabel Fernandez-Bachiller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE)
Shu Liu et al.
BMC STRUCTURAL BIOLOGY (2012)
Fragment screening to predict druggability (ligandability) and lead discovery success
Fredrik N. B. Edfeldt et al.
DRUG DISCOVERY TODAY (2011)
Inhibition of β-Secretase in Vivo via Antibody Binding to Unique Loops (D and F) of BACE1
Lujia Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values
Chresten R. Sondergaard et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions
Mats H. M. Olsson et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
Normal Mode Analysis of Biomolecular Structures: Functional Mechanisms of Membrane Proteins
Ivet Bahar et al.
CHEMICAL REVIEWS (2010)
Understanding and Predicting Druggability. A High-Throughput Method for Detection of Drug Binding Sites
Peter Schmidtke et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Structural and Thermodynamic Characteristics of the Exosite Binding Pocket on the Human BACE1: A Molecular Modeling Approach
Lucas J. Gutierrez et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2010)
Fpocket: An open source platform for ligand pocket detection
Vincent Le Guilloux et al.
BMC BIOINFORMATICS (2009)
Interaction models of substrate peptides and β-secretase studied by NMR spectroscopy and molecular dynamics simulation
Jee-Young Lee et al.
MOLECULES AND CELLS (2009)
γ-secretase inhibition and modulation for Alzheimer's disease
Michael S. Wolfe
CURRENT ALZHEIMER RESEARCH (2008)
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice
Lisa McConlogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Design, synthesis, and X-ray structure of potent memapsin 2 (β-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
β-Secretase (BACE-1) inhibitors:: Accounting for 10s loop flexibility using rigid active sites
Georgia B. McGaughey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Comparison of multiple amber force fields and development of improved protein backbone parameters
Viktor Hornak et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Alzheimer therapeutics-what after the cholinesterase inhibitors?
Lary C. Walker et al.
AGE AND AGEING (2006)
Functional plasticity in the substrate binding site of β-secretase
AA Gorfe et al.
STRUCTURE (2005)
An inhibitor binding pocket distinct from the catalytic active site on human β-APP cleaving enzyme
MG Kornacker et al.
BIOCHEMISTRY (2005)
Evolutionarily conserved functional mechanics across pepsin-like and retroviral aspartic proteases
M Cascella et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Structural locations and functional roles of new subsites S5, S6, and S7 in memapsin 2 (β-secretase)
RT Turner et al.
BIOCHEMISTRY (2005)
Flap position of free memapsin 2 (β-secretase), a model for flap opening in aspartic protease catalysis
L Hong et al.
BIOCHEMISTRY (2004)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Apo and inhibitor complex structures of BACE (β-secretase)
S Patel et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Determination of the active site protonation state of β-secretase from molecular dynamics simulation and docking experiment:: Implications for structure-based inhibitor design
H Park et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
The β-secretase, BACE -: A prime drug target for Alzheimer's disease
R Vassar
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
Subsite specificity of memapsin 2 (β-secretase):: Implications for inhibitor design
RT Turner et al.
BIOCHEMISTRY (2001)
BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain:: implications for Alzheimer's disease therapeutics
SL Roberds et al.
HUMAN MOLECULAR GENETICS (2001)
Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
L Hong et al.
SCIENCE (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
